Silverleafe Capital Partners LLC Invests $1.24 Million in Corteva, Inc. (NYSE:CTVA)

Silverleafe Capital Partners LLC purchased a new position in Corteva, Inc. (NYSE:CTVA - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 21,572 shares of the company's stock, valued at approximately $1,244,000. Corteva makes up approximately 0.5% of Silverleafe Capital Partners LLC's investment portfolio, making the stock its 29th biggest holding.

Several other hedge funds have also bought and sold shares of the stock. Rise Advisors LLC grew its holdings in Corteva by 2,522.2% during the 1st quarter. Rise Advisors LLC now owns 472 shares of the company's stock valued at $27,000 after purchasing an additional 454 shares during the last quarter. CVA Family Office LLC bought a new position in Corteva during the 4th quarter valued at about $25,000. Ironwood Wealth Management Inc. grew its holdings in Corteva by 106.1% during the 1st quarter. Ironwood Wealth Management Inc. now owns 544 shares of the company's stock valued at $31,000 after purchasing an additional 280 shares during the last quarter. Scarborough Advisors LLC bought a new position in Corteva during the 4th quarter valued at about $29,000. Finally, BKM Wealth Management LLC bought a new position in Corteva during the 4th quarter valued at about $27,000. Hedge funds and other institutional investors own 81.54% of the company's stock.

Corteva Stock Performance

Shares of NYSE:CTVA traded up $0.29 during midday trading on Friday, reaching $53.94. The company's stock had a trading volume of 6,301,369 shares, compared to its average volume of 3,420,539. The firm has a market capitalization of $37.60 billion, a PE ratio of 68.28, a P/E/G ratio of 1.43 and a beta of 0.78. Corteva, Inc. has a twelve month low of $43.22 and a twelve month high of $58.76. The stock has a fifty day moving average of $54.77 and a 200 day moving average of $52.78. The company has a quick ratio of 0.97, a current ratio of 1.51 and a debt-to-equity ratio of 0.10.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings results on Wednesday, May 1st. The company reported $0.89 EPS for the quarter, beating the consensus estimate of $0.79 by $0.10. The company had revenue of $4.49 billion for the quarter, compared to analyst estimates of $4.65 billion. Corteva had a net margin of 3.32% and a return on equity of 6.68%. The firm's revenue was down 8.0% on a year-over-year basis. During the same quarter last year, the business earned $1.16 earnings per share. On average, equities analysts expect that Corteva, Inc. will post 2.8 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 18th. Investors of record on Tuesday, June 4th were given a dividend of $0.16 per share. The ex-dividend date was Tuesday, June 4th. This represents a $0.64 annualized dividend and a yield of 1.19%. Corteva's dividend payout ratio is presently 81.01%.

Wall Street Analysts Forecast Growth

CTVA has been the subject of several research reports. Oppenheimer boosted their price objective on shares of Corteva from $67.00 to $69.00 and gave the company an "outperform" rating in a research report on Friday, May 3rd. OTR Global reaffirmed a "negative" rating on shares of Corteva in a research report on Friday, June 7th. KeyCorp upped their price target on shares of Corteva from $63.00 to $66.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 9th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and set a $65.00 target price on shares of Corteva in a research report on Wednesday, June 12th. Finally, Wolfe Research assumed coverage on shares of Corteva in a research report on Friday, March 1st. They set an "outperform" rating and a $67.00 target price for the company. One investment analyst has rated the stock with a sell rating, six have given a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $63.00.

Insider Activity at Corteva

In other Corteva news, insider Samuel R. Eathington sold 31,686 shares of the stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $57.64, for a total transaction of $1,826,381.04. Following the transaction, the insider now directly owns 53,854 shares of the company's stock, valued at $3,104,144.56. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other Corteva news, insider Samuel R. Eathington sold 31,686 shares of the stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $57.64, for a total transaction of $1,826,381.04. Following the transaction, the insider now directly owns 53,854 shares of the company's stock, valued at $3,104,144.56. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Brian Titus sold 12,134 shares of the stock in a transaction on Monday, May 6th. The shares were sold at an average price of $56.65, for a total transaction of $687,391.10. Following the transaction, the insider now directly owns 13,495 shares in the company, valued at $764,491.75. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 83,556 shares of company stock worth $4,795,016. 0.14% of the stock is owned by company insiders.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.